U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07629375) titled 'Standardization of a Platform of Preclinical Models Derived From NSCLC Patients' on Nov. 18, 2025.
Brief Summary: Characterize and trace innovative nutraceuticals based on microencapsulated resveratrol and Cynara cardunculus extract, using preclinical models such as organotypic tissue slices and tumoroids created from tumor fragments derived from patients with non-small cell lung cancer. This will enable the development of combination therapies to increase the efficacy of immunotherapy in NSCLC and reduce side effects that lead to treatment discontinuation.
The market implementation of these products may offer unique advantages, inc...